Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
A. Campo Ezquibela (Pamplona, Spain), P. Yuste Olmos (Pamplona, Spain), M. Ocon De Miguel (Pamplona, Spain), A. Alcaide Ocaña (Pamplona, Spain), J. De Torres Tajes (Pamplona, Spain), J. Berto Botella (Pamplona, Spain), J. Pueyo Villoslada (Pamplona, Spain), M. Lozano Escario (Pamplona, Spain), J. Zulueta Francés (Pamplona, Spain). Risk factors and prognosis of non-solid nodules in a lung cancer screening program. 3026

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Risk factors for lung cancer worldwide Source: Eur Respir J 2016; 48: 889-902 Year: 2016 Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Risk factors for vascular events during lung cancer chemotherapy Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Is smoking status a prognostic factor in resected lung cancer? Source: ISSN=ISSN 1810-6838, ISBN=, page=78 Year: 2006 Preoperative biopsy risk for recurrence?: A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017 Screening for lung cancer Source: Eur Respir Mon; 2009: 44: 57–70 Year: 2009 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Prevalence and burden of bronchiectasis in a lung cancer screening program Source: International Congress 2019 – Airway infection in COPD Year: 2019 Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017